| 中文名 | 三七皂甙 R1 |
|---|---|
| 英文名 | notoginsenoside R1 |
| 中文别名 |
三七皂苷R1(分析标准品)
人参皂苷R1 三七皂苷 三七皂苷R1(HPLC-UV ,HPLC-ELSD ) 三七皂苷 FB 三七皂苷R1对照品 三七根提取物 药典标准 2020 三七皂甙R1(标准品) 三七皂苷 R1, 来源于三七 NOTOGINSENOSIDE R1 三七皂苷R1 三七皂苷-FP2 NOTOGINSENOSIDE R1 三七皂苷R1 标准品 (2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-(((2R,3R,4S,5S,6R)-4,5-二羟基-6-(羟甲基)-3-(((2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-3,12-二羟基-4,4,8,10,14-五甲基十六氢-1H-环戊并[A]菲-17-基)-6-甲基庚-5-烯-2-基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇 三七叶提取物 三七叶皂甙 三七皂苷R1标准品/人参皂苷R1标准品 抑制剂Notoginsenoside R1 三七皂苷R1对照品/人参皂苷R1对照品 三七皂甙R1 三七皂苷R1,10 MM DMSO 溶液 4-羧基苯硼酸/4-Cboxyphenylboronic acid 三七皂苷R1标准品 三七皂苷R1(人参皂苷R1) 三七皂甙R1(对照品) |
| 英文别名 |
Sanchinoside R1
Sanqi glucoside R1 notogisenoside R1 Notoginsenoside R1 from Panax notoginseng (Burk.)F.H.Chen (3beta,6alpha,12beta)-20-(beta-D-Glucopyranosyloxy)-3,12-dihydroxydamm-24-en-6-yl 2-O-beta-D-Xylopyranosyl-beta-D-glucopyranoside β-D-Glucopyranoside, (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydamm-24-en-6-yl 2-O-β-D-xylopyranosyl ginsenoside-Rg2 Notoginsenoside R1 Standd NotoginsenosideR1 Notoginsenoside Fb TIANFU-CHEM Notoginsenoside R1 Notoginsenoside R1,Sanchinoside R1 (2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,12-dihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylht-5-en-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol Notoginsenoside R1 Impurity Notoginseng saponin FP2 Notoginsenoside R1, 10 mM in DMSO NOTOGINSENOSIDE R1(SH) notoginsenoside Rh1 NOTOGINSENOSIDE 2-[2-[6-[[4,5-dihydroxy-6-(hydroxymethyl)-3-methyl-2-oxanyl]oxy]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylht-5-en-2 NOTOGINSENOSIDE R1 Notoginseng saponin R1 Panax Notoginseng Saponins, PNS Notoginseng extracts Notoginsenoside R1-RM (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylht-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol (3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-β-D-xylopyranosyl-β-D-glucopyranoside glucopyranosyloxy)-3,12-dihydroxydamm-24-en-6-yl2-O-β-D-xylopyranosyl Panax notoginseng saponin R1 (3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydamm-24-en-6-yl 2-O-β-D-xylopyranosyl-β-D-glucopyranoside |
| 描述 | 三七皂苷R1 (Notoginsenoside R1) 三七的主要活性成分,据报道有神经保护、抗高血压的作用。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 1010.5±65.0 °C at 760 mmHg |
| 熔点 | 218 °C |
| 分子式 | C47H80O18 |
| 分子量 | 933.127 |
| 闪点 | 564.9±34.3 °C |
| 精确质量 | 932.534485 |
| PSA | 298.14000 |
| LogP | 4.42 |
| 外观性状 | white to off-white |
| 蒸汽压 | 0.0±0.6 mmHg at 25°C |
| 折射率 | 1.614 |
| 储存条件 | -20°C |
| 水溶解性 | H2O: soluble1mg/mL, clear, colorless |
| 计算化学 | 1.疏水参数计算参考值(XlogP):1.1 2.氢键供体数量:12 3.氢键受体数量:18 4.可旋转化学键数量:12 5.互变异构体数量:无 6.拓扑分子极性表面积298 7.重原子数量:65 8.表面电荷:0 9.复杂度:1670 10.同位素原子数量:0 11.确定原子立构中心数量:25 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302 |
| 危害码 (欧洲) | Xn |
| 风险声明 (欧洲) | 22 |
| 安全声明 (欧洲) | 24/25 |
| 危险品运输编码 | NONH for all modes of transport |
| 海关编码 | 29389090 |